Il parlamentare, economista e psicologo norvegese spiega perché ci serve un nuovo modo di comunicare il cambiamento climatico
Archivi categoria: futuro
Per Espen Stoknes ad HuffPost: “Dire che ‘moriremo tutti’ non risolve il problema del cambiamento climatico’” ùnuovo modo di comunicare il cambiamento climatico
Wildfires, cosmic rays and ancient-human hybrids are some of this year’s top stories.
Each year, Jeff Bezos writes an open letter to Amazon’s shareholders. Over the last two decades, these letters have become an unparalleled source of insight into how the world’s richest man — and his company — think about customers, innovation, building products, and more.
The Collins English Dictionary ’s top 10 words of 20181 included “plogging” (picking up litter while jogging), “VAR” (video assistant referee), and “floss” (a new dance craze). So, as The BMJ heads to the New Year, here’s my personal list of the top words of 2018 for UK health services. I’ve doubtless missed some, so please do post rapid responses or tweet your own suggestions. It’s been good to see, for the first time in the NHS’s history, a draft workforce plan (technically, a “strategy”)—from Health Education England.2 It has its imperfections, but at least it’s a plan. And we’re eagerly expecting the launch of NHS England’s 10 year plan for the health service.3 Again, not everyone will be happy with its details, but a shift towards medium term plans beats short term, politically driven cycles. It’s a start. To my mind,4 and …
Se il Regno Unito lascia l’Unione Europea senza un accordo, le forniture di farmaci potrebbero affrontare “un momento catastrofico”, secondo Martin Sawer, direttore esecutivo della Healthcare Distribution Association.
Ma la Brexit non porta problemi. Dicono (in Italia)
Ricordo che il BMJ e’ l’organo ufficiale dell’ordine dei medici inglesi …
Availability of drugs—including blood products, insulin, and nuclear medicines—and treatment of rare diseases are some of the areas where uncertainty caused by UK-EU negotiations is increasingly concerning doctors, suppliers, and patients If the UK leaves the European Union without a deal in place, supplies of drugs could face “a catastrophic time,” according to Martin Sawer, executive director of the Healthcare Distribution Association. Two types at particular risk are insulin and biological medicines, including those derived from blood plasma—because the UK relies on imported supplies. The six week buffer stock that health secretary Matt Hancock has asked drug companies to set up in case of short term border disruption is straightforward (if costly) for drugs with a long shelf life. It is trickier for those that need to be kept at a controlled, low temperature during transport and storage. Mike Thompson, chief executive of the Association of the British Pharmaceutical Industry, told the Commons select committee no deal Brexit inquiry on 23 October1 that the government’s contingency plans were insufficient. There were no cold chain storage facilities at the ports in the event o
Sorgente: Braced for Brexit | The BMJ
Tag: rischio clinico